| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |